Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Procter & Gamble ( (PG) ) has issued an update.
On December 9, 2025, Procter & Gamble announced that Jennifer Davis, the current Chief Executive Officer of their Health Care division, will retire on June 30, 2026, after over 33 years with the company. Her departure marks a significant transition for the company, potentially impacting its leadership dynamics and strategic direction within the health care sector.
The most recent analyst rating on (PG) stock is a Hold with a $152.00 price target. To see the full list of analyst forecasts on Procter & Gamble stock, see the PG Stock Forecast page.
Spark’s Take on PG Stock
According to Spark, TipRanks’ AI Analyst, PG is a Neutral.
Procter & Gamble’s overall stock score is driven by its strong financial performance and positive corporate events, which are offset by bearish technical indicators and valuation concerns. The earnings call highlighted strategic strengths but also pointed to market share challenges and restructuring efforts. The company’s solid dividend yield provides some support to the valuation.
To see Spark’s full report on PG stock, click here.
More about Procter & Gamble
Average Trading Volume: 8,850,622
Technical Sentiment Signal: Sell
Current Market Cap: $333.8B
Find detailed analytics on PG stock on TipRanks’ Stock Analysis page.